S
Silvio E. Inzucchi
Researcher at Yale University
Publications - 511
Citations - 64889
Silvio E. Inzucchi is an academic researcher from Yale University. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 92, co-authored 424 publications receiving 54101 citations. Previous affiliations of Silvio E. Inzucchi include University of Toronto & American Diabetes Association.
Papers
More filters
Journal ArticleDOI
Growth hormone and the maintenance of adult bone mineral density.
TL;DR: The effects of GH on mature bone, the findings of studies on the skeletal effects ofGH in adults, and the potential use of GH as an anabolic agent in the treatment of osteoporosis are considered.
Five-Year Outcomes in "High-Risk" Participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study. A Post-Hoc Analysis. Running Title: High Risk Participants in the DIAD Study
Shanti Bansal,Frans J Th Wackers,Silvio E. Inzucchi,Deborah Chyun,Janice A. Davey,Lawrence H. Staib,Lawrence H. Young,J Frans +7 more
Journal ArticleDOI
Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes.
Silvio E. Inzucchi,Melanie J. Davies,Kamlesh Khunti,Prabhav Trivedi,Jyothis T. George,Isabella Zwiener,Odd Erik Johansen,Naveed Sattar +7 more
TL;DR: To investigate the association of different categories of baseline cardio‐metabolic risk factors on the treatment effects of empagliflozin 10 and 25 mg when added as second‐line therapy to metformin in patients with type 2 diabetes (T2D).
Journal ArticleDOI
Design and rationale for the Cardiovascular and Metabolic Effects of Lorcaserin in Overweight and Obese Patients-Thrombolysis in Myocardial Infarction 61 (CAMELLIA-TIMI 61) trial.
Erin A. Bohula,Benjamin M. Scirica,Christina L. Fanola,Silvio E. Inzucchi,Anthony C Keech,Darren K. McGuire,Steven R. Smith,Tim Abrahamsen,Bruce Francis,Wenfeng Miao,Carlos Perdomo,Andrew Satlin,Stephen D. Wiviott,Marc S. Sabatine +13 more
TL;DR: The safety and efficacy of lorcaserin for MACEs and conversion to diabetes in overweight or obese patients with established cardiovascular disease or multiple cardiovascular risk factors is investigated.
Journal ArticleDOI
Reports of Lactic Acidosis Attributed to Metformin, 2015–2018
TL;DR: The increased reports deserve attention, but the proportionate reporting ratio (PRR), a measure adjusted for rates of other adverse event reports, was stable and did not permit the conclusion that U.S. MALA rates have increased.